SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001689375-22-000010
Filing Date
2022-08-11
Accepted
2022-08-11 07:07:11
Documents
14
Period of Report
2022-08-11
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K trda-20220811.htm   iXBRL 8-K 36955
2 EX-99.1 trda-20220811x8kxexhibit991.htm EX-99.1 50222
6 LOGO image_0a.jpg GRAPHIC 30141
  Complete submission text file 0001689375-22-000010.txt   277656

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT trda-20220811.xsd EX-101.SCH 1911
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT trda-20220811_lab.xml EX-101.LAB 24927
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT trda-20220811_pre.xml EX-101.PRE 13141
8 EXTRACTED XBRL INSTANCE DOCUMENT trda-20220811_htm.xml XML 11675
Mailing Address 6 TIDE STREET BOSTON MA 02210
Business Address 6 TIDE STREET BOSTON MA 02210 857-305-1825
Entrada Therapeutics, Inc. (Filer) CIK: 0001689375 (see all company filings)

IRS No.: 813983399 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40969 | Film No.: 221153642
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences